Integrated health industry city site that will be a world model for self-sustained growth of human resources and technology (COI-NEXT)Integrated health industry city site that will be a world model for self-sustained growth of human resources and technology (COI-NEXT)

TOPICS

  • Topics
  • Activity report
  • Results
  • Acknowledgement

Report on the 4th Startup Seminar

The 4th Startup Seminar was held on Monday, November 25th.
This time, the seminar was titled "Pharmaceutical Manufacturers and Academia Roundtable," and participants discussed how research professors and startups should interact with pharmaceutical manufacturers from the perspectives of pharmaceutical manufacturers and academia. It was a very meaningful seminar, as we were able to hear specific and frank opinions about challenges and ideal situations regarding collaboration with pharmaceutical manufacturers.

We would like to express our sincere gratitude to everyone who participated. Please join us for future startup seminars!

◆ JST COI-NEXT Program × Life Science Incubation Council
Pharmaceutical Manufacturers and Academia Roundtable
· Date snd time : November 25th (Mon), 2024 18:00-19:30 JST
· The venue : LINK-J WEST

· Speakers :
(Moderator)
Cabinet Office Bioeconomy Strategy Expert/LSIC
Organizer, Lawyer Yoshizawa Nao
(Panelists)
Shiono Soichi, Shionogi & Co., Ltd.
Maeda Tomoko, Nippon Boehringer Ingelheim Co., Ltd.
Suzuki Shinobu, Kyoto University

Report on the 4th Startup Seminar

Report on the 4th Startup Seminar

Report on the 3rsup>rd Startup Seminar

The 3sup>rd Startup Seminar was held on Tuesday, November 5th.
This time, we held a VC capitalist roundtable discussion, with Mikio Kawahara of Utokyo Innovation Platform Co., Ltd., Hiroyuki Hasegawa of Mitsubishi UFJ Capital Co., Ltd., and Hajime Oshita of Medventure partners,Inc.. They discussed what kind of healthcare startups VCs are looking for and what points to consider when evaluating them.

We would like to express our sincere gratitude to everyone who participated. Please join us for future startup seminars!

◆ JST COI-NEXT Program × Life Science Incubation Council
VC capitalist roundtable
· Date snd time : November 5th (Tue), 2024 18:00-19:30 JST
· The venue : LINK-J WEST

· Speakers :
Utokyo Innovation Platform Co., Ltd. Mikio Kawahara
Mitsubishi UFJ Capital Co.,Ltd. Hiroyuki Hasegawa
Medventure partners, Inc. Hajime Oshita

Report on the 3rd Startup Seminar

Report on the 3rd Startup Seminar Upcoming Startup Seminars

Panel Discussion Report [ BioJapan2024 ]

On Friday, October 11th, we co-hosted a panel discussion with the Life Science Incubation Council at BioJapan, featuring life science industry associations from Japan, the US, the UK, and Canada.
This time, we invited representatives from Newsight Tech Angels (Japan), Life Science Nation (US), MedCity (UK), and BioQuebec (Canada), which have long supported the globalization of startups around the world, to discuss how startups should utilize industry associations and partners in each country to advance globalization.

Thank you to everyone who attended.

◆ JST COI-NEXT Program × Life Science Incubation Council
BioJapan 2024 Panel Discussion inviting the life science sector organizations from Japan, US, UK and Canada
· Timing of the seminar : October 11th (Fri), 2024 15:35-16-35 JST
· Place of the seminar : BioJapan2024 Event Hall Presentation Stage D

· Speakers : 
Mr Nao Yoshizawa, Founder, Life Science Incubation Council
Dr Tsuneaki Sakata, Chairman, NPO kinki Bio-Industry Development Organization
Mr Shigehiro Asano, Director, NCVC
Mme Helene Moore, BioQuebec
Ms Claire Jeong, Vice President, Life Science Nations
Ms Angela Kukula, CEO, MedCity

BioJapan 2024 Panel Discussion inviting the life science sector organizations from Japan, US, UK and Canada

BioJapan 2024 Panel Discussion inviting the life science sector organizations from Japan, US, UK and Canada

BioJapan Exhibition Report

We exhibited at a booth at BioJapan, which was held at PACIFICO YOKOHAMA from October 9th to 11th.
Osaka Prefecture, NCVC, and COI-NEXT(NCVC) exhibited jointly. As COI-NEXT(NCVC), we introduced the Kento Imaging Support Center and startup support issues.

Thank you to everyone who visited our booth during the event.

◆ BioJapan
· Date and Time : October 9th (Wed) - October 11th (Sun) 10:00 - 17:00
· The venue : PACIFICO YOKOHAMA (A-42)
· Contents : Panel exhibits (introductions to the COI-NEXT (NCVC), the Kento Imaging Support Center, startup support issues, etc.)

BioJapan Exhibition Report

BioJapan Exhibition Report

Report on exhibiting at the 83rd Annual Meeting of the Japanese Cancer Association

We exhibited at the 83rd Annual Meeting of the Japanese Cancer Association, held from September 19th to 21st, and promoted the Kento Imaging Support Center.

Thank you to everyone who visited our booth during the event.

◆ the 83rd Annual Meeting of the Japanese Cancer Association
· Date and Time : September 19th (Thu) – September 21st (Sun)
· The venue : Fukuoka International Congress Center, Marine Messe Fukuoka Hall B
· Contents : Panel exhibits (the Kento Imaging Support Center)

Report on exhibiting at the 83rd Annual Meeting of the Japanese Cancer Association

Report on the 3rd Progress Report Meeting of the PI Development Program

On Friday, October 4th, the third progress report meeting of the PI Development Program was held.
Three of the nine researchers selected for the PI Development Program gave presentations on the progress of their research, and there was lively discussion between the organizers and other recipients.

The next general meeting, including the recipients and organizers of the PI Development Program, is scheduled to be held on-site (January 2025).

Report on the 3rd Progress Report Meeting of the PI Development Program

Report on the 3rd Progress Report Meeting of the PI Development Program

Report on participating in the " Pre-EXPO Medical care in the Future "

On Friday, September 27th, we participated in the “Future Medical Pre-EXPO” held at Nakanoshima Qross. This international event aims to promote the potential and efforts of life sciences in Osaka and Kansai to the Kansai Consul General and industry, as well as to deepen exchanges between overseas stakeholders and companies.
At this event, PL Mochizuki gave a presentation as the leader of the Biocommunity Kansai (BiocK) Subcommittee on Digital Biohealth. We also exhibited posters promoting the COI-NEXT program (NCVC).

L) PL Mochizuki's presentation   R) Posters L) PL Mochizuki's presentation   R) Posters

L) Poster exhibition venue   R) Official mascot of the Osaka-Kansai Expo (MYAKU-MYAKU) L) Poster exhibition venue   R) Official mascot of the Osaka-Kansai Expo (MYAKU-MYAKU)

Startup Seminar [Special Edition] Report

On Wednesday, September 18th, we held a "Startup Seminar [Special Edition]".
This time, we invited speakers representing Mayo Clinic, the world's largest non-profit, comprehensive medical group in the United States, to speak about collaboration between the hospital and Japanese companies, and support for Japanese startups expanding into the US.In addition to clinical work, Mayo Clinic is engaged in a variety of research programs, translational research, and building an ecosystem for medical startups.

This time, more than 50 people participated, even though the event was held early in the morning.
We look forward to seeing you at the next Startup Seminar.

Startup Seminar [Special Edition] Report

Startup Seminar [Special Edition] Report

2024.11.11
The following press release was issued by project leader Mochizuki Naoki and Yamagata University School of Medicine.
Zonated Wnt/β-catenin signal-activated cardiomyocytes at the atrioventricular canal promote coronary vessel formation in zebrafish
2024.09.19
There was a press release on the study of Dr. Takahisa Furukawa, the leader of R&D theme 5.
Ccrk-Mak/Ick signaling is a ciliary transport regulator essential for retinal photoreceptor survival
2024.09.17
Nobuhiro Nakai (Kobe University), a recipient of the PI Development Program, has been selected for the FY2024 “Advanced Research & Development Programs for Medical (AMED-PRIME)”. (in Japanese only.)
2024.08.28
There was a press release on the study of Dr. Hiroshi Seno, the leader of R&D theme 2.
Early detection of pancreatic cancer by comprehensive serum miRNA sequencing with automated machine learning
2024.06.25
Atsushi Mitsuhashi (Tokushima University), a recipient of the PI Development Program, has been selected for the FY2023 “ Fusion oriented Research for disruptive Science and Technology (JST). (in Japanese only.)
2022.10.25
There was a press release on the study of Dr. Yoshihiro Kokubo, the leader of R&D Issue No. 6.
A high WBC count can predict atrial fibrillation: The Suita Study.
2022.08.24
There was a press release on the study of Dr. Yoshihiro Kokubo, the leader of R&D Issue No. 6.
Serum uric acid levels associated with risk of diabetes mellitus in peri- and postmenopausal women living in urban areas.

When research related to this program or research using the equipment installed in the "Kento Imaging Support Center" is published in a paper, it will be introduced on the website of the Place for Co-Creation and reported to JST as an achievement.

[ Research related to this program ]
Please indicate your grant number below.
Grant number of the Co-Creation Field: JPMJPF2018
When your paper is accepted, please inform the Co-Creation Field Support Office.
We will publish your paper as a result on the website of Place for Co-Creation.

( For inquiries, please contact )
National Cerebral and Cardiovascular Center
Open Innovation Center, Industry-Academia Collaboration Division
6-1 Kishibe Shinmachi, Suita City, Osaka, Japan
E-mail: coi-next-so@ml.ncvc.go.jp
TEL: 06-6170-1070

List of TOPICS >

  • Northern Osaka Health and Biomedical Innovation Town KENTO
  • National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN)
  • National University Corporation Tokushima University
  • Eisai Co., Ltd.
  • Towa Pharmaceutical Co., Ltd.
  • Sysmex Corporation
  • Nipro Corporation
  • JSR Corporation
  • CYBERDYNE, Inc.
  • crossEffect, Inc.
  • CMIC HOLDINGS Co., Ltd.
  • Osaka Chamber of Commerce and Industry
  • Osaka Prefectural Government
  • Suita City
  • Settsu City
  • Mediford Corporation
  • Mizuho Bank, Ltd.
  • Kobe University
  • AIR WATER INC.
  • Kowa Company, Ltd.
  • JSPA(Japan Selfcare Promotion Association)
  • The SC approved MUFG Bank
  • Hankyu Hanshin Holdings Co., Ltd.
  • JCR Pharma Co., Ltd.
  • NEXGEN Co., Ltd.
  • Kyoto University
  • Osaka University
  • Shiga University of Medical Science
  • Kobe Pharmaceutical University
  • Osaka Metropolitan University
  • The Research Foundation for Microbial Diseases of Osaka University
  • Wellier Corporation
  • General Incorporated Association KENTO Co-Creation Promotion Organization (KCOP)